Early pregnancy screening for pre-eclampsia: a proteomic based model for identifying high-risk patients.

先兆子痫的早期妊娠筛查：用于识别高危患者的基于蛋白质组学的模型。

• 批准号: nhmrc : 1039119
• 负责人: Dr Lisa Harris
• 金额: $ 8.12万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/early-pregnancy-screening-risk-patients/111251
• 关键词: Early; pregnancy; screening; pre; eclampsia

Pre-eclampsia is a serious medical condition affecting 5% of pregnancies and resulting in significant mortality and morbidity for mothers and babies. As yet there is no acceptable test capable of detecting pre-eclampsia in early pregnancy and diagnosis is made when symptoms and signs are manifest and management options are limited to early delivery. This project is designed to assess the ability of a blood screening test to detect pre-eclampsia in early pregnancy to enable for early interventions and preventative management to be implemented.

先兆子痫是一种严重的医学病症，影响5%的妊娠，并导致母亲和婴儿的显著死亡率和发病率。到目前为止，还没有可接受的测试能够检测先兆子痫在怀孕早期和诊断时，症状和体征是明显的和管理选项仅限于早期分娩。该项目旨在评估血液筛查检测在妊娠早期发现先兆子痫的能力，以便实施早期干预和预防性管理。